SLOT: Full Definition
What is liraglutide?
Liraglutide is the generic name for a once-daily injectable GLP-1 receptor agonist sold under two brand names: Saxenda for chronic weight management and Victoza for type 2 diabetes. Both products contain the same molecule; they differ in approved indication and maximum daily dose. Liraglutide was the first GLP-1 medication to be FDA-approved for weight management (Saxenda, 2014) and remains a useful option, particularly for women who do not tolerate the longer-acting weekly GLP-1 agonists.
At Modern Thyroid Clinic, liraglutide is one of several tools we consider for women whose weight, appetite, or insulin signaling is not responding to lifestyle work alone — especially those with insulin resistance, PCOS, or post-menopausal weight gain.
How does liraglutide work?
Liraglutide mimics glucagon-like peptide-1 (GLP-1), a hormone the gut releases after a meal. By binding to GLP-1 receptors, it:
- Slows stomach emptying, increasing fullness after meals
- Reduces appetite signals in the brain
- Stimulates insulin release in a glucose-dependent way (so it does not typically cause low blood sugar in non-diabetics)
- Lowers glucagon, the hormone that raises blood sugar between meals
Because liraglutide is short-acting compared to weekly options, it is dosed once daily by subcutaneous injection. Side effects are also more dose-responsive day to day, which some patients find easier to manage.
When is liraglutide prescribed?
Liraglutide is prescribed in two main contexts:
- Saxenda (3.0 mg): chronic weight management for adults with BMI ≥ 30, or BMI ≥ 27 with a weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
- Victoza (up to 1.8 mg): type 2 diabetes management, often added when Metformin alone is insufficient
Liraglutide may be considered when weekly options like semaglutide or tirzepatide are not available, not tolerated, or not covered.
Patient considerations
The most common side effects are gastrointestinal — nausea, diarrhea, constipation, and occasionally reflux — and usually improve as the body adjusts. Liraglutide carries the same boxed warning as other Glp 1 Agonists regarding medullary thyroid cancer and MEN-2 syndrome, so it is not used in patients with that history. Pancreatitis is a rare but real risk. Daily injections require commitment, and stopping the medication usually leads to some weight regain unless durable lifestyle changes are in place. As with any prescription, the decision to start liraglutide should be made with a clinician who can evaluate the full picture — thyroid, hormones, metabolic labs, and goals.
Common symptoms
Common questions
What is the difference between Saxenda and Victoza?
Both are liraglutide, but they are FDA-approved for different uses and at different doses. Saxenda is approved for chronic weight management, dosed up to 3.0 mg daily. Victoza is approved for type 2 diabetes, dosed up to 1.8 mg daily. The pen devices and strengths are different, and insurance coverage typically depends on the diagnosis on file. Clinically the active medication is identical, so the choice often comes down to indication, formulation, and what your insurance will cover. A clinician can help match the right product to your situation.
How is liraglutide different from semaglutide?
Both are GLP-1 receptor agonists, but liraglutide is shorter-acting (once daily) while semaglutide is once-weekly. Semaglutide tends to produce somewhat greater weight loss and blood sugar improvement in head-to-head data, which is why it has largely replaced liraglutide as the first-line GLP-1 choice. Liraglutide remains valuable when patients prefer daily dosing, when supply of weekly agents is limited, or when its shorter half-life makes side effects easier to manage. Tirzepatide (Mounjaro/Zepbound) is a newer dual-receptor option with even greater average effect.
Will liraglutide help with PCOS or insulin resistance?
Often, yes. Liraglutide improves insulin sensitivity, reduces appetite, and supports modest-to-moderate weight loss — all of which help underlying drivers of [polycystic-ovary-syndrome] and insulin resistance. Many women see better cycles, lower fasting insulin, and reduced food cravings on this class of medication. At Modern Thyroid Clinic we often combine GLP-1 therapy with nutrition, strength training, and sleep work, because the medication is most powerful when paired with foundational metabolic care rather than used in isolation.
Think you might be dealing with this?
Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.
Book a Discovery CallThis content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.